bsg
MicroEEG
Biosignal Group
bsg bsg bsg bsg bsg bsg bsg bsg bsg bsg bsg bsg
About BSG
Bio-Signal Group’s (BSG) mission is to enable functional brain monitoring anywhere at any time, for everyone. Our initial solution is the microEEG® System, a small, wireless, easy-to-use brain monitoring system designed specifically for use in the Emergency Department.

BSG was founded in 2002 by Dr. André Fenton to commercialize a proprietary digital telemetry (DT) technology. Since its founding, BSG has worked on developing new applications for DT, and . . . More About BSG
BSG Profiles
andre fenton
André Fenton (PhD)
President

André Fenton (PhD), a BSG founder and the President, is Professor of Neural Science at the Center for Neural Science at New York University. Recently, Dr. Fenton used BSG’s ITS (Interactive Tracking System) to identify PKMζ as the first molecular mechanism of long-term memory storage (Pastalkova et al., 2006). This work was recognized by Science as one of 10 major breakthroughs in 2006 … (more)

John Gridley
John Gridley (M.P.P.)
CEO

John Gridley, a BSG founder and the CEO, became a full-time employee of the company in 2004. Mr. Gridley previously worked for 4 years as Finance and Business Development Director of an internet software start-up, Centrum Holdings BV, funded in part by Intel Capital’s venture fund. The company successfully exited to a private equity fund for a valuation reported … (more)

Anderson Micu
Anderson Micu (M.S.E.E.)
COO

Anderson Micu (M.S.E.E.) is the Chief Operating Officer of BSG. He has 14 years of engineering and management experience in commercial product line design, development, testing, manufacturing and support, including 4 years as the founder and CEO of a successful electronic consumer product start-up company. Mr. Micu has demonstrated a solid track record of working within budgetary … (more)

BSG News
May 2012  The microEEG® System is selected to ascertain subclinical seizures/seizure freedom in pediatric patients with cerebral malaria receiving enteral Levetiracetam (LVT). The unique features of the BSG's system also allows for continuously monitoring 2-3 patients simultaneously in the compact area occupied by the Queen Elizabeth Center Hospital in Malawi. The two year study is funded by NINDS and affiliated with Michigan State University. (Link)
May 2012   BSG’s clinical trial results on the use of the microEEG® System in the Emergency Department, has been selected for the Plenary Session at the Society of American Emergency Medicine (SAEM) in Chicago on May 9-12. This work has been selected over 1,100 abstracts to represent the best research in the Emergency Medicine field. The session is scheduled for presentation on Thursday, May 10, 4:30 - 6:00 PM
May 2012   The microEEG® System diagnostic utility in identifying aberrant electrographic categories in Emergency Department patients with Altered Mental Status, has been selected for a Moderated Poster Presentation at the SAEM 2012 Annual Meeting in Chicago on May 9-12. The abstract has been scheduled for presentation on Saturday, May 12, 1:00 - 2:00 PM.
For scientific instruments go to
research.biosignalgroup.com
microEEG® Videos
microEEG® System vs. Standard EEG System
This side by side comparison demonstrates the ease-of-use and speed of the microEEG® System.
microEEG® System Demonstration
Dr. André Fenton demonstrates an early working prototype to the SUNY Board of Trustees.